Porter CEO battling CRA over tax bill from 'significant losses' from 'high-risk' pandemic trading
Article content
Article content
When the COVID-19 pandemic hit Canada in March 2020, Porter's top executive Michael Deluce saw opportunity. As economies suddenly shuttered and investors scrambled to grapple with the global pandemics, markets experienced some of the largest one-day swings in nearly four decades.
Article content
Article content
According to a document filed to the Tax Court of Canada, Deluce noticed market volatility and decided to liquidate an investment portfolio containing low-risk investments that would generate capital, but only in the long-term.
Article content
Article content
Instead, Deluce put the funds into a self-managed investing account and swung for the stars.
Article content
According to an appeal he filed in court, the airline executive thought he could make significant amounts of money by investing in high-risk exchange-traded funds (ETF).
Article content
He tried to short the S&P 500 index because he had a 'very pessimistic view' of the market's reaction to the pandemic and thought he could 'profit off a potential fall of the stock market'.
Article content
On March 20 — the same day Porter suspended all flights for what would become 18 months — Deluce invested in an ETF focused on the price of futures contracts on crude oil, the document shows. His bet was that oil prices would rise within days after plummeting in early March amid a sharp dip in demand in the U.S. (they did not).
Article content
Article content
'(Deluce) traded high-risk investment products with the intention of capitalizing on the volatility of the market caused by the Covid-19 pandemic, and to realize significant short-term profits,' reads his appeal.
Article content
Article content
But Deluce's gamble did not pay off. His appeal states that he incurred 'significant losses' in his attempt to bet against the S&P 500, and losses in the four days he bet on oil prices rising starting March 20, 2020, but some gains from purchasing and selling units of a third ETF on March 26, 2020.
Article content
After eight months of trading, he had accrued nearly $5.8 million in investment losses as well as interest fees on the loans he took out to fund his trades, according to his filing.
Article content
Deluce is the son of Robert Deluce, who founded Porter Airlines in 2006 after a lengthy battle with the City of Toronto about development at Billy Bishop Toronto City Airport where the airline is headquartered. Michael Deluce was named CEO of Porter Airlines in 2019 and Robert Deluce assumed the role of executive chairman.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Winnipeg Free Press
3 hours ago
- Winnipeg Free Press
Asian shares advance ahead of Trump's deadline for imposing higher tariffs on Chinese goods
BANGKOK (AP) — Shares advanced in Asia on Monday, a day ahead of U.S. President Donald Trump's deadline for imposing higher tariffs on goods imported from China. Markets in Japan and Thailand were closed for holidays. The Hang Seng in Hong Kong edged 0.2% higher to 24,908.37, while the Shanghai Composite index gained 0.5% to 3,653.50. Triple digit tariffs imposed by Trump and Beijing were paused for 90 days in May to allow time for talks. Tuesday is the deadline for extending that truce. The last round of negotiations, held last month in Stockholm, ended without a clear word from Trump on whether the deadline would be extended for another 90 days. Elsewhere in Asia, Australia's S&P/ASX 200 rose 0.3% to 8,831.40, while the Kospi in South Korea was nearly unchanged, at 3,210.76. On Friday, the S&P 500 rose 0.8% to 6,389.45, just shy of its record high. The Dow Jones Industrial Average added 0.5% to 44,175.61, and the Nasdaq rose 1% to finish at 21,450.02. Technology companies, with their hefty stock values, did much of the heavy lifting for the market. Nvidia rose 1.1% and Apple gained 4.2%. Gilead Sciences jumped 8.3% for one of the market's biggest gains after reporting financial results that easily beat analysts' forecasts, while also raising its earnings forecast for the year. Expedia Group rose 4.1% after also reporting encouraging financial results. They are among the final big batch of companies within the S&P 500 to report mostly strong financial results for the second quarter. Still, many have warned that current tariffs could cut into their profits. Elsewhere in the market, entertainment giant Paramount Skydance slid 10.5% a day after the company was created by the closing of an $8 billion merger of Skydance and Paramount. Shares in rival Warner Bros. Discovery sank 8%. Investors will get more insight this week on U.S. inflation at both the consumer and wholesale levels and on retail sales. Trump's trade war and its potential impact on the U.S. economy and on the Federal Reserve's interest rate policy are a focus after the U.S. began imposing higher import taxes on dozens of countries last Thursday. Monday Mornings The latest local business news and a lookahead to the coming week. The Fed's last decision to hold interest rates steady included two votes to lower interest rates. Its next meeting is in September, and Wall Street is overwhelmingly betting that the central bank will cut interest rates by a quarter of a percentage point after signals have pointed to a weaking of the economy. Both are key concerns for the Fed, which has been trying to cool inflation down to its target rate of 2% while also fulfilling its 'full employment' mandate. Lower interest rates can give the economy and investment prices a boost, though the downside is that they can also push inflation higher. Concerns about inflation reheating could be overshadowed by worries about a weakening employment market. In other dealings early Monday, U.S. benchmark crude oil shed 38 cents to $63.50 per barrel. Brent crude, the international standard, declined 31 cents to $66.28 per barrel. The U.S. dollar slipped to 147.46 Japanese yen from 147.62 yen. The euro rose to $1.1673 from $1.1650.
Japan Forward
4 hours ago
- Japan Forward
Shionogi Eyes US Plant to Boost Antibiotic Production Amid Tariffs Challenge
このページを 日本語 で読む United States President Donald Trump has stated plans to gradually increase tariffs on pharmaceuticals to as high as 250%. In response, Shionogi & Company, Limited President Isao Teshirogi announced on August 7 that the firm is considering building a new manufacturing plant in the US. The facility would produce Cefiderocol (brand name Fetroja), a drug for treating Gram-negative bacterial infections, which is in high demand in the US. Teshirogi revealed the plan in an interview with The Sankei Shimbun , adding that the plant is expected to be completed by January 2029, while Trump is still in office. Cefiderocol is currently produced exclusively at Shionogi's factory in Kanegasaki Town, Iwate Prefecture. If the plan goes ahead, the new facility would mark the company's first pharmaceutical manufacturing plant in the US. The firm is already evaluating the supply chain for the raw materials needed for construction, as well as securing land and personnel for the project. US President Donald Trump speaks at the White House, July 31, Washington (©Reuters via Kyodo) "If relying entirely on overseas pharmaceutical supplies poses a national security threat, then I agree," Teshirogi said, showing an understanding of Trump's policy. "I believe it's reasonable to want to accelerate and vigorously promote [domestic manufacturing]." "The ultimate goal is to save patients. If President Trump says, 'I want this product to be made in the US,' then we need to consider building a factory to meet that demand," he added. "We are already developing concrete plans for construction so we can act swiftly in line with the administration's direction." Regarding financing the project, Teshirogi said, "We will also require subsidies from the US government to support the construction of the new plant." Shionogi Pharmaceutical Research Center in Toyonaka City, Osaka (©Sankei by Yuta Yasumoto) The drug Cefiderocol is effective against infections caused by multidrug-resistant bacteria, meaning bacteria that have developed resistance to many other antibiotics. It's currently sold in Japan, the United States, and Europe, with demand growing, especially in the US. Drawing lessons from the COVID-19 pandemic, the Japanese pharmaceutical maker emphasizes the importance of promoting local production overseas to mitigate supply chain risks. "We are planning to launch Cefiderocol in the US around 2030 or 2040. If we do so, building a factory [there] is unavoidable," the company president said. However, specialized facilities are required to produce the antibiotics that become the raw materials for Cefiderocol. Manufacturing these antibiotics is complex, and there seem to be few of these facilities in the US. Therefore, securing skilled engineers could be challenging. Furthermore, China holds a near-monopoly on the supply of active ingredients for the antibiotics, "making it even more difficult to produce them at fermentation plants in the US," Teshirogi noted. Shionogi's president acknowledged that transferring manufacturing technology and securing a stable supply of raw materials would be the biggest hurdles ahead. Author: Yohei Ushijima, Sarasa Shimizu (The Sankei Shimbun) このページを 日本語 で読む
Calgary Herald
14 hours ago
- Calgary Herald
Hedge funds flip on green energy and start betting against oil
Article content For green investors, it's been 'less bad than expected,' said Nishant Gupta, founder and chief investment officer of Kanou Capital LLP, an energy transition-focused hedge fund. 'There's been more protection around US domestic production than expected.' Article content And this year's tariff wars have coincided with a broad rebound in green stocks. Since Trump first unveiled his proposed tariffs on April 2 — dubbed Liberation Day by the White House — the main S&P index tracking clean energy stocks has added about 18%. Over the same period, the main S&P index for oil companies is down around 4%. Article content Much of the clean-energy rebound has been driven by solar. The Invesco Solar ETF, a widely tracked exchange-traded fund packed with solar stocks, is up more than 18% since April 2. Article content More hedge funds continue to be short stocks in the Kraneshares Electric Vehicles and Future Mobility Index ETF than long — a constant since 2021 as China has steadily displaced Western manufacturers. But the share of net shorts dropped to 2.87% in June, which is the second-lowest level in almost half a decade. Article content Article content At the same time, there's an expectation among fund managers that the continued rise in sales of EVs globally will reduce the need for petroleum. That matches BloombergNEF estimates, which anticipate a 25% annual increase in EV sales this year. BNEF also expects that about 40% of vehicles on the road could be electric by 2040, displacing 19 million barrels of oil a day by that year. Article content The strategy shift among funds reflects the fact that economic growth without low-carbon energy is now inconceivable, according to Trium's Mares. Article content 'If we are going to continue to grow both in developed and emerging economies, we're going to need a lot of energy,' he said. 'A big chunk of the marginal growth in energy over the last 10 years has come from renewables and it's hard to see why that isn't going to continue.' Article content MethodologyBloomberg Green analyzed anonymized weekly data that around 700 hedge fund managers disclosed to Hazeltree, from January 2021 through 27 June 2025. The hedge funds in the Hazeltree database vary in terms of assets under management, and the analysis is not weighted by hedge fund assets or size of position held. Collectively, AUM for the hedge funds analyzed is around $700 billion. Total assets under management in the hedge fund industry were around $4.7 trillion at the end of the second quarter 2025, according to Hedge Fund Research. Bloomberg also interviewed hedge fund managers on their oil and energy transition bets and on trends from the data analysis. Article content Article content Hedge funds mostly provided their data to Hazeltree via prime brokers. There is a possibility that some positions may not be disclosed. These will not be included in Hazeltree's data or in the Bloomberg analysis. Article content Hazeltree's data reports percentages of the hedge funds that held net long positions and net short positions for a specific stock. Bloomberg's analysis categorized roughly 230 stocks based on key ETFs or indices for a sector, and further calculated a sector-wide monthly average. In some cases, the same company could be included in different sectors. Four stocks didn't appear in the Hazeltree data provided to Bloomberg.
